Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002040 · ClinicalTrials.gov registry record · NA

Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis

A NA study of HIV Infections and Meningitis, Cryptococcal, sponsored by Pfizer.

Completed
Registry status
NA
Development phase
5
Study locations

NCT00002040 is a NA study of HIV Infections and Meningitis, Cryptococcal that has completed, run by Pfizer. The trial reports 5 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002040, a NA study of HIV Infections and Meningitis, Cryptococcal, has completed, sponsored by Pfizer.

COMPLETED
Registry status
NA
Development phase
5
Study locations

Study Summary

To evaluate the safety and effectiveness of fluconazole as an intravenous dose as initial treatment for acute cryptococcal meningitis followed by oral therapy in AIDS and non-AIDS patients. Both newly diagnosed and relapsed patients are eligible. The effectiveness of maintenance fluconazole therapy in sustaining a clinical cure in AIDS patients will also be evaluated.

Conditions Studied

HIV Infections Meningitis, Cryptococcal

Interventions

  • DRUG Fluconazole

Study Locations (5)

New York

  • SUNY / Health Sciences Ctr at Brooklyn - Brooklyn
  • Cornell Univ Med Ctr - New York

California

  • Summitt Med Ctr / San Francisco Gen Hosp - Oakland

Illinois

  • Cook County Hosp - Chicago

Pennsylvania

  • Buckley Braffman Stern Med Associates - Philadelphia

Trial Details

FieldValue
Phase NA

Sponsor

Pfizer

1,845 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00002040

The ClinicalTrials.gov registry entry for NCT00002040 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Fluconazole is the first listed.

NCT00002040 reports 5 study locations spanning 4 distinct geographic areas - top geographies include New York, California, Illinois.

Frequently Asked Questions

What is clinical trial NCT00002040 about?

NCT00002040 is a clinical study titled "Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis". To evaluate the safety and effectiveness of fluconazole as an intravenous dose as initial treatment for acute cryptococcal meningitis followed by oral therapy in AIDS and non-AIDS patients. Both newly diagnosed and relapsed patients are eligible. The effectiveness of maintenance fluconazole therapy ...

What is the current status of trial NCT00002040?

This trial is currently completed. It is a NA study.

What conditions does trial NCT00002040 study?

This clinical trial studies the following conditions: HIV Infections, Meningitis, Cryptococcal.

What interventions are being tested in trial NCT00002040?

The interventions under investigation include: Fluconazole (DRUG).

Who is sponsoring clinical trial NCT00002040?

This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00002040 being conducted?

This trial has 5 study locations across California, Illinois, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

Meningitis, Cryptococcal

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.